Stepan's Portfolio of U.S. EPA-Approved Products Effective Against the Novel Coronavirus that Causes COVID-19




As health and safety organizations continue to closely monitor the respiratory disease caused by 2019 novel coronavirus (COVID-19), many have asked if Stepan has any U.S. EPA-approved registrations eligible for environmental infectious control of COVID-19 under the U.S. EPA's emerging viral pathogen guidance 

Stepan does offer 20 U.S. EPA-registered end use formulations that meet the criteria for applications against emerging viral pathogens, and therefore may be considered for use as hard surface disinfectants against SARS-CoV-2, the novel coronavirus that causes the disease COVID-19. Stepan expects additional approvals in May 2020. 

Emerging Viral Pathogen Claim Table
Subregistrants with a pre-qualified emerging viral pathogen claim can include a defined efficacy statement off-label in technical literature, non-label-related, websites, consumer information services, and social media sites, in accordance with the U.S. EPA's policy.
Along with a dedicated biocide team, we have a comprehensive portfolio of over 80 U.S. EPA-approved end use formulations that sanitize and disinfect in a wide variety of applications, including household and institutional cleaning, water treatment, oilfield and wood preservation. Please let us know how we can support you. If you would like to learn more or have any questions, please call 1-800-745-7837 or contact the Stepan Company North America Technical Service Department at



Powered by GlobalLink OneLink Software